TY - JOUR
T1 - CRISIS AFAR
T2 - an international collaborative study of the impact of the COVID-19 pandemic on mental health and service access in youth with autism and neurodevelopmental conditions
AU - Vibert, Bethany
AU - Segura, Patricia
AU - Gallagher, Louise
AU - Georgiades, Stelios
AU - Pervanidou, Panagiota
AU - Thurm, Audrey
AU - Alexander, Lindsay
AU - Anagnostou, Evdokia
AU - Aoki, Yuta
AU - Birken, Catherine S.
AU - Bishop, Somer L.
AU - Boi, Jessica
AU - Bravaccio, Carmela
AU - Brentani, Helena
AU - Canevini, Paola
AU - Carta, Alessandra
AU - Charach, Alice
AU - Costantino, Antonella
AU - Cost, Katherine T.
AU - Cravo, Elaine A.
AU - Crosbie, Jennifer
AU - Davico, Chiara
AU - Donno, Federica
AU - Fujino, Junya
AU - Gabellone, Alessandra
AU - Geyer, Cristiane T.
AU - Hirota, Tomoya
AU - Kanne, Stephen
AU - Kawashima, Makiko
AU - Kelley, Elizabeth
AU - Kim, Hosanna
AU - Kim, Young Shin
AU - Kim, So Hyun
AU - Korczak, Daphne J.
AU - Lai, Meng Chuan
AU - Margari, Lucia
AU - Marzulli, Lucia
AU - Masi, Gabriele
AU - Mazzone, Luigi
AU - McGrath, Jane
AU - Monga, Suneeta
AU - Morosini, Paola
AU - Nakajima, Shinichiro
AU - Narzisi, Antonio
AU - Nicolson, Rob
AU - Nikolaidis, Aki
AU - Noda, Yoshihiro
AU - Nowell, Kerri
AU - Polizzi, Miriam
AU - Portolese, Joana
AU - Riccio, Maria Pia
AU - Saito, Manabu
AU - Schwartz, Ida
AU - Simhal, Anish K.
AU - Siracusano, Martina
AU - Sotgiu, Stefano
AU - Stroud, Jacob
AU - Sumiya, Fernando
AU - Tachibana, Yoshiyuki
AU - Takahashi, Nicole
AU - Takahashi, Riina
AU - Tamon, Hiroki
AU - Tancredi, Raffaella
AU - Vitiello, Benedetto
AU - Zuddas, Alessandro
AU - Leventhal, Bennett
AU - Merikangas, Kathleen
AU - Milham, Michael P.
AU - Di Martino, Adriana
N1 - Funding Information:
This work was partially supported by grants from the National Institute of Mental Health (R01MH105506, R01MH115363) and gifts to the Child Mind Institute (CMI) from Dr. John and Consuela Phelan for support of ADM; and from Phyllis Green and Randolph Cowen for MPM. We would also like to thank the many individuals who have provided financial support to the CMI Healthy Brain Network to make the creation and sharing of this resource possible; the Italian Ministry of Health, Ricerca Corrente 2021/2.06 to A.N., R.T. and G.M; The Ontario COVID & Kids Mental Health Study is funded by the Canadian Institutes for Health Research (#173092); the Ontario Ministry of Health (#700); Centre of Brain and Mental Health, SickKids; Leong Centre for Healthy Children, SickKids; and the Miner’s Lamp Innovation Fund in Prevention and Early Detection of Severe Mental Illness, University of Toronto. In-kind support was provided by the Ontario Brain Institute for all POND-CMH data. Spit for Science was funded by the Canadian Institutes of Health Research (PJT-159462). The views of the Ontario COVID & Kids Mental Health Study do not necessarily represent those of the Province of Ontario and the Ontario Ministry of Health.
Funding Information:
First and foremost, we are immensely grateful to all parents/caregivers and their children who generously contributed their time during the pandemic, one of the most challenging times for humankind in this century. We are also grateful to the research and clinical staff members at each contributing site supporting different aspects of collection of the AFAR survey data and the pre-pandemic clinical phenotypic data. We thank Irene Droney at CMI for support in the development and curation of the AFAR website, and RedCap data structure, Dr. Greg Kiar at CMI for helpful discussions about random forest classification, and Dr. Marco Pagani for helpful discussions on the use of NbClust in R. We are also thankful to Dr. Shafali Jeste for sharing the preprint version of the service survey developed during the pandemic for individuals with syndromic intellectual disabilities and their caregivers that we adopted to develop the AFAR service-related questions. Finally, it is with profound sadness that we wish to remember the clinical and scientific acumen, as well as unwavering dedication to child psychiatry of our coauthor, Professor Alessandro Zuddas, MD, who prematurely passed away after completion of the originally submitted manuscript.
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Background: Heterogeneous mental health outcomes during the COVID-19 pandemic are documented in the general population. Such heterogeneity has not been systematically assessed in youth with autism spectrum disorder (ASD) and related neurodevelopmental disorders (NDD). To identify distinct patterns of the pandemic impact and their predictors in ASD/NDD youth, we focused on pandemic-related changes in symptoms and access to services. Methods: Using a naturalistic observational design, we assessed parent responses on the Coronavirus Health and Impact Survey Initiative (CRISIS) Adapted For Autism and Related neurodevelopmental conditions (AFAR). Cross-sectional AFAR data were aggregated across 14 European and North American sites yielding a clinically well-characterized sample of N = 1275 individuals with ASD/NDD (age = 11.0 ± 3.6 years; n females = 277). To identify subgroups with differential outcomes, we applied hierarchical clustering across eleven variables measuring changes in symptoms and access to services. Then, random forest classification assessed the importance of socio-demographics, pre-pandemic service rates, clinical severity of ASD-associated symptoms, and COVID-19 pandemic experiences/environments in predicting the outcome subgroups. Results: Clustering revealed four subgroups. One subgroup—broad symptom worsening only (20%)—included youth with worsening across a range of symptoms but with service disruptions similar to the average of the aggregate sample. The other three subgroups were, relatively, clinically stable but differed in service access: primarily modified services (23%), primarily lost services (6%), and average services/symptom changes (53%). Distinct combinations of a set of pre-pandemic services, pandemic environment (e.g., COVID-19 new cases, restrictions), experiences (e.g., COVID-19 Worries), and age predicted each outcome subgroup. Limitations: Notable limitations of the study are its cross-sectional nature and focus on the first six months of the pandemic. Conclusions: Concomitantly assessing variation in changes of symptoms and service access during the first phase of the pandemic revealed differential outcome profiles in ASD/NDD youth. Subgroups were characterized by distinct prediction patterns across a set of pre- and pandemic-related experiences/contexts. Results may inform recovery efforts and preparedness in future crises; they also underscore the critical value of international data-sharing and collaborations to address the needs of those most vulnerable in times of crisis.
AB - Background: Heterogeneous mental health outcomes during the COVID-19 pandemic are documented in the general population. Such heterogeneity has not been systematically assessed in youth with autism spectrum disorder (ASD) and related neurodevelopmental disorders (NDD). To identify distinct patterns of the pandemic impact and their predictors in ASD/NDD youth, we focused on pandemic-related changes in symptoms and access to services. Methods: Using a naturalistic observational design, we assessed parent responses on the Coronavirus Health and Impact Survey Initiative (CRISIS) Adapted For Autism and Related neurodevelopmental conditions (AFAR). Cross-sectional AFAR data were aggregated across 14 European and North American sites yielding a clinically well-characterized sample of N = 1275 individuals with ASD/NDD (age = 11.0 ± 3.6 years; n females = 277). To identify subgroups with differential outcomes, we applied hierarchical clustering across eleven variables measuring changes in symptoms and access to services. Then, random forest classification assessed the importance of socio-demographics, pre-pandemic service rates, clinical severity of ASD-associated symptoms, and COVID-19 pandemic experiences/environments in predicting the outcome subgroups. Results: Clustering revealed four subgroups. One subgroup—broad symptom worsening only (20%)—included youth with worsening across a range of symptoms but with service disruptions similar to the average of the aggregate sample. The other three subgroups were, relatively, clinically stable but differed in service access: primarily modified services (23%), primarily lost services (6%), and average services/symptom changes (53%). Distinct combinations of a set of pre-pandemic services, pandemic environment (e.g., COVID-19 new cases, restrictions), experiences (e.g., COVID-19 Worries), and age predicted each outcome subgroup. Limitations: Notable limitations of the study are its cross-sectional nature and focus on the first six months of the pandemic. Conclusions: Concomitantly assessing variation in changes of symptoms and service access during the first phase of the pandemic revealed differential outcome profiles in ASD/NDD youth. Subgroups were characterized by distinct prediction patterns across a set of pre- and pandemic-related experiences/contexts. Results may inform recovery efforts and preparedness in future crises; they also underscore the critical value of international data-sharing and collaborations to address the needs of those most vulnerable in times of crisis.
KW - Autism spectrum disorder
KW - Behavioral problems
KW - COVID-19 pandemic
KW - Mental health outcomes
KW - Neurodevelopmental conditions
KW - Prediction
KW - Public health
KW - Risk and resilience factors
KW - Sleep
UR - http://www.scopus.com/inward/record.url?scp=85148058242&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85148058242&partnerID=8YFLogxK
U2 - 10.1186/s13229-022-00536-z
DO - 10.1186/s13229-022-00536-z
M3 - Article
C2 - 36788583
AN - SCOPUS:85148058242
SN - 2040-2392
VL - 14
JO - Molecular Autism
JF - Molecular Autism
IS - 1
M1 - 7
ER -